About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

STELLA PHARMA CORPORATION(4888) Financial Results

4888
TSE Growth
STELLA PHARMA CORPORATION
536
JPY
-11
(-2.01%)
Dec 23, 3:30 pm JST
3.42
USD
Dec 23, 1:30 am EST
Result
PTS
outside of trading hours
ー
ー
Summary Chart Historical News Financial Result
Current Period Guidance
Annual
Result
Guidance History
Growth Rate
Profitability
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2021 ＊ 205 -680 -656 -659 -32.9 0 May 10, 2021 J-GAAP
Mar, 2022 100 -741 -764 -767 -27.3 0 May 10, 2022 J-GAAP
Mar, 2023 229 -806 -775 -778 -27.0 0 May 9, 2023 J-GAAP
Mar, 2024 269 -760 -760 -763 -24.7 0 May 10, 2024 J-GAAP
Mar, 2025 Guidance 930 -252 -257 -260 -7.6 0 May 10, 2024 J-GAAP
YoY +245.7% +66.8% +66.2% +65.9% +69.0%
All-Time High
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record 417 -680 29 19 97.1
Fiscal Year Dec, 2015 Mar, 2021 Dec, 2015 Dec, 2015 Dec, 2015
Second Half
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2021 31 -404 -358 -359 -12.8 0 May 10, 2022 J-GAAP
Oct - Mar, 2022 137 -440 -433 -434 -15.0 0 May 9, 2023 J-GAAP
Oct - Mar, 2023 116 -459 -457 -458 -14.8 0 May 10, 2024 J-GAAP
Oct - Mar, 2024 Guidance 761 17 10 8 0.2 0 Nov 8, 2024 J-GAAP
YoY +556.0% － － － －
Cash Flow
Annual
Fiscal Year Operating Profit Fee Cash Flow Operating Cash Flow Investing Cash Flow Financial Cash Flow Cash & Equivalents Cash Ratio Accounting Standards
Mar, 2022 -741 -1,431 -1,081 -350 3,829 3,235 68.57 J-GAAP
Mar, 2023 -806 -856 -827 -29 291 2,669 61.65 J-GAAP
Mar, 2024 -760 -885 -876 -9 228 2,012 52.67 J-GAAP
Actual Performance and Financial Trends
Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2022 92 -366 -342 -344 -12.0 ー Nov 9, 2022 J-GAAP
Apr - Sep, 2023 153 -301 -303 -305 -10.0 ー Nov 9, 2023 J-GAAP
Apr - Sep, 2024 169 -269 -267 -268 -8.2 ー Nov 8, 2024 J-GAAP
YoY +10.5% +10.6% +11.9% +12.1% +17.5%
Quarterly Results
Result
Growth Rate
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2022 83 -137 -138 -139 -4.9 -165.1 Feb 10, 2023 J-GAAP
Jan - Mar, 2023 54 -303 -295 -295 -10.2 -561.1 May 9, 2023 J-GAAP
Apr - Jun, 2023 61 -163 -164 -165 -5.4 -267.2 Aug 8, 2023 J-GAAP
Jul - Sep, 2023 92 -138 -139 -140 -4.6 -150.0 Nov 9, 2023 J-GAAP
Oct - Dec, 2023 47 -165 -163 -164 -5.3 -351.1 Feb 13, 2024 J-GAAP
Jan - Mar, 2024 69 -294 -294 -294 -9.5 -426.1 May 10, 2024 J-GAAP
Apr - Jun, 2024 61 -166 -161 -161 -5.1 -272.1 Aug 7, 2024 J-GAAP
Jul - Sep, 2024 108 -103 -106 -107 -3.3 -95.4 Nov 8, 2024 J-GAAP
YoY +17.4% +25.4% +23.7% +23.6% +28.2%
All-Time High Quarterly Results
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record 108 -103 -106 -107 -3.3
Fiscal Year Sep, 2024 Sep, 2024 Sep, 2024 Sep, 2024 Sep, 2024
Key Balance Sheet Figures
Fiscal Year BPS Equity Ratio Total Asset Equity Retained Earnings Interest-Bearing Debt Ratio Announce Accounting Standards
Mar, 2022 107.39 65.3 4,718 3,079 -2,636 0.41 May 10, 2022 J-GAAP
Mar, 2023 91.51 63.3 4,329 2,742 -778 0.40 May 9, 2023 J-GAAP
Mar, 2024 75.90 62.0 3,820 2,370 -763 0.39 May 10, 2024 J-GAAP
Apr - Sep, 2024 ー 59.2 5,205 3,079 -268 0.28 Nov 8, 2024 J-GAAP